参考文献
徐韬园. (2011). 也谈精神分裂症的分型问题 . 上海精神医学, 23, 106–108.
杨欣译, 杜明哲 , 刘慧婷, Opler, M. (2011). 亚型分类在理解精神分裂症疾病进程中的作用 : “缺陷综合征”的举例. 上海精神医学, 23, 109–111.
Allardyce, J., Gaebel, W., Zielasek, J., & van Os, J. (2007). Deconstructing psychosis conference February 2006: The validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophrenia Bulletin, 33, 863–867.
Allen, A. J., Griss, M. E., Folley, B. S., Hawkins, K. A., & Pearlson, G. D. (2009). Endophenotypes in schizophrenia: A selective review. Schizophrenia Research, 109(1), 24–37.
Barch D. M., Bustillo, J., Gaebel, W., Gur, R., Heckers, S., Malaspina, D., … Carpenter, W. (2013). Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: Relevance to DSM-5. Schizophrenia Research, 150(1), 15–20.
Braff, D. L., Ryan, J., Rissling, A. J., & Carpenter, W. T. (2013). Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophrenia Bulletin, 39, 751–753.
Bromet, E. J., Kotov, R., Fochtman, L. J., Carlson, G. A., Tanenberg-Karant, M., Ruggero, C., & Change, S. W. (2011). Diagnostic shifts during the decade following first admission for psychosis. American Journal of Psychiatry, 168, 1186–1194.
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., … Keller, W. (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36, 71–93.
Carpenter, W. T., & Stephens, J. H. (1979). An attempted integration of information relevant to schizophrenic subtypes. Schizophrenia Bulletin, 5, 490–506.
Coltheart, M., Langdon, R., & McKay, R. (2011). Delusional belief. Annual Review of Psychology, 62, 271–298.
Cuthbert, B. N., & Insel, T. R. (2010). Toward new approaches to psychotic disorders: The NIMH research domain criteria project. Schizophrenia Bulletin, 36, 1061–1062.
Demjaha, A., Morgan, K., Morgan, C., Landau, S., Dean, K., Reichenberg, A., … Dazzan, P. (2009). Combining dimensional and categorical representation of psychosis: The way forward for DSM-V and ICD-11? Psychological Medicine, 39, 1943–1955.
Der-Avakian, A., & Markou, A. (2012). The neurobiology of anhedonia and other reward-related deficits. Trends in Neuroscience, 35, 68–77.
Dikeos, D. G., Wickham, H., McDonald, C., Walshe, M., Sigmundsson, T., Bramon, E., … Sham, P. C. (2006). Distribution of symptom dimensions across Kraepelinian divisions. British Journal of Psychiatry, 189, 346–353.
Dixon, L. B., Dickerson, F., Bellack, A. S., Bennett, M., Dickinson, D., Goldberg, R. W., … Kreyenbuhl, J. (2010). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin, 36, 48–70.
Farooq, S., Agid, O., Foussias, G., & Remington, G. (2013). Using treatment response to subtype schizophrenia: Proposal for a new paradigm in classification. Schizophrenia Bulletin, 39, 1169–1172.
Fink, M., & Taylor, M. A. (2008). Issues for DSM-V: The medical diagnostic model. American Journal of Psychiatry, 165, 799.
Gaebel, W. (2012). Status of psychotic disorders in ICD-11. Schizophrenia Bulletin, 38, 895–898.
Guggenheim, G. F., & Babigian, M. H. (1974). Diagnostic consistency in catatonic schizophrenia. Schizophrenia Bulletin, 1(11), 103–108.
Haahr, U., Friis, S., Larsen, T. K., Melle, I., Johannessen, J. O., Opjordsmoen, S., … McGlashan, T. (2007). First-episode psychosis: Diagnostic stability over one and two years. Psychopathology, 41, 322–329.
Harvey, P. D., Green, M. F., Bowie, C., & Loebel, A. (2006). The dimensions of clinical and cognitive change in schizophrenia: Evidence for independence of improvements. Psychopharmacology, 187, 356–363.
Heckers, S. (2008). Making progress in schizophrenia research. Schizophrenia Bulletin, 34, 591–594.
Heckers, S., Barch, D. M., Bustillo, J., Gaebel, W., Gur, R., Malaspina, D., … Carpenter, W. (2013). Structure of the psychotic disorders classification in DSM-5. Schizophrenia Research, 150(1), 11–14.
Heckers, S., Tandon, R., & Bustillo, J. (2010). Catatonia in the DSM—shall we move or not? Schizophrenia Bulletin, 36, 205–207.
Keller, W. R., Fischer, B. A., & Carpenter, W. T. Jr. (2011).
Revisiting the diagnosis of schizophrenia: Where have we been and where are we going? CNS Neuroscience & Therapeutics, 17(2), 83–88.
Kendell, R., & Jablensky, A. (2003). Distinguishing between the validity and utility of psychiatric diagnoses. American Journal of Psychiatry, 160, 4–12.
Kendler, K. S., Gruenberg, A. M., & Tsuang, M. T. (1985). Subtype stability in schizophrenia. American Journal of Psychiatry, 142, 827–832.
Keshavan, M. S. (2013). Nosology of psychoses in DSM-5: Inches ahead but miles to go. Schizophrenia Research, 150(1), 40–41.
Keshavan, M. S., Tandon, R., Boutros, N. N., & Nasrallah, H.
A. (2008). Schizophrenia, “just the facts”: What we know in 2008: Part 3: Neurobiology. Schizophrenia Research, 106(2–3), 89–107.
Linscott, R. J., Allardyce, J., & van Os, J. (2010). Seeking verisimilitude in a class: A systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophrenia Bulletin, 36, 811–829.
Lykouras, L., Oulis, P., Daskalopoulou, E., Psarros, K., & Christodoulou, N. G. (2001). Clinical subtypes of schizophrenic disorders: A cluster analytic study. Psychopathology, 34, 23–28.
Mattila, T., Koeter, M., Wohlfarth, T., Storosum, J., van den Brink, W., de Haan, L., … Denys, D. (2015). Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia. Schizophrenia Bulletin, 41, 637–643.
Messinger, J. W., Trémeau, F., Antonius, D., Mendelsohn, E., Prudent, V., Stanford, A. D., & Malaspina, D. (2011). Avolition and expressive deficits capture negative symptom phenomenology: Implications for DSM-5 and schizophrenia research. Clinical Psychology Review, 31, 161–168.
Nemeroff, C. B., Weinberger, D., Rutter, M., MacMillan, H. L., Bryant, R. A., Wessely, S., … Lysaker, P. (2013). DSM-5: A collection of psychiatrist views on the changes, controversies, and future directions. BMC Medicine, 11, 202.
Peralta, V., Campos, M. S., de Jalon. E. G., & Cuesta, M. J. (2010). DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: Psychometric validity and response to antipsychotic medication. Schizophrenia Research, 118(1–3), 168–175.
Picardi, A., Viroli, C., Tarsitani, L., Miglio, R., de Girolamo, G., Dell’Acqua, G., & Biondi, M. (2012). Heterogeneity and symptom structure of schizophrenia. Psychiatry Research, 198, 386–394.
Regier, D. A., Narrow, W. E., Clarke, D. E., Kraemer, H. C., Kuramoto, S. J., Kuhl, E. A., & Kupfer, D. J. (2014). DSM-5 field trials in the United States and Canada, Part II: Test-retest reliability of selected categorical diagnoses.
American Journal of Psychiatry, 170, 59–70.
Reininghaus, U., Priebe, S., & Bentall, R. P. (2013). Testing the psychopathology of psychosis: Evidence for a general psychosis dimension. Schizophrenia Bulletin, 39, 884–895.
Rodríguez-Testal, J. F., Senín-Calderón, C., & Perona-Garcelán,
S. (2014). From DSM-IV-TR to DSM-5: Analysis of some changes. International Journal of Clinical and Health Psychology, 14, 221–231.